Rheumatoid arthritis.
Much has been learned about the interactions of immunologic events and the development of musculoskeletal disease. Much more needs to be learned. The partnership of astute clinicians and investigators will enhance this learning process and eventually benefit the health and well being of our patients, and perhaps, humankind.